Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
Clinical trial NCT02121990 · COMPLETED
Trial details
- NCT number
- NCT02121990
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-21
- Primary completion
- 2020-08-19
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.